LifeMD, Inc.
LFMD
$6.52
$0.0851.32%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 37.74% | 43.07% | 39.27% | 42.16% | 38.63% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 37.74% | 43.07% | 39.27% | 42.16% | 38.63% |
Cost of Revenue | 54.43% | 45.77% | 27.34% | 13.52% | 12.62% |
Gross Profit | 35.66% | 42.71% | 40.96% | 46.42% | 42.73% |
SG&A Expenses | 21.20% | 30.98% | 36.93% | 38.24% | 32.54% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | 34.81% | 31.82% | 45.65% | 47.04% | 32.52% |
Total Operating Expenses | 25.37% | 33.12% | 36.86% | 37.04% | 31.64% |
Operating Income | 89.43% | 58.27% | -11.43% | -0.83% | 10.30% |
Income Before Tax | 79.16% | 52.66% | -5.26% | 16.67% | 22.28% |
Income Tax Expenses | -6.07% | -6.07% | -6.07% | 83.12% | 18.66% |
Earnings from Continuing Operations | 77.74% | 51.71% | -4.99% | 15.30% | 21.76% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 31.52% | 75.52% | 94.44% | 87.65% | 18.60% |
Net Income | 74.77% | 54.06% | 8.32% | 21.85% | 21.56% |
EBIT | 89.43% | 58.27% | -11.43% | -0.83% | 10.30% |
EBITDA | 97.93% | 64.67% | -10.22% | 0.15% | 10.99% |
EPS Basic | 69.79% | 55.38% | 23.47% | 35.03% | 33.09% |
Normalized Basic EPS | 77.20% | 62.52% | 28.66% | 31.52% | 24.96% |
EPS Diluted | 69.54% | 54.39% | 23.13% | 34.25% | 32.36% |
Normalized Diluted EPS | 77.00% | 62.33% | 28.66% | 31.52% | 24.96% |
Average Basic Shares Outstanding | 13.19% | 17.93% | 21.64% | 22.42% | 19.88% |
Average Diluted Shares Outstanding | 14.80% | 19.64% | 21.64% | 22.42% | 19.88% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -2.96% | -1.18% | -0.09% | -0.28% | -0.27% |